Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?

Gregory T. Brennan, MD, Alex Duong, Emily T. Nguyen, PharmD and Douglas L. Nguyen, MD
Cleveland Clinic Journal of Medicine December 2018, 85 (12) 923-924; DOI: https://doi.org/10.3949/ccjm.85a.18037
Gregory T. Brennan
Gastroenterology Fellow, Department of Medicine, Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex Duong
Student, Department of Medicine Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily T. Nguyen
Pharmacist, Department of Pharmacy, University of California Irvine Medical Center, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas L. Nguyen
Associate Professor, Department of Medicine, Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 85 no. 12 923-924
DOI 
https://doi.org/10.3949/ccjm.85a.18037
PubMed 
30526752

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online December 1, 2018.

Copyright & Usage 
Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Gregory T. Brennan, MD
  1. Gastroenterology Fellow, Department of Medicine, Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  1. Alex Duong
  1. Student, Department of Medicine Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  1. Emily T. Nguyen, PharmD
  1. Pharmacist, Department of Pharmacy, University of California Irvine Medical Center, Irvine, CA
  1. Douglas L. Nguyen, MD⇑
  1. Associate Professor, Department of Medicine, Division of Gastroenterology, University of California Irvine Medical Center, Irvine, CA
  1. ADDRESS:
    Douglas L. Nguyen, MD, Department of Medicine, Division of Gastroenterology, University of California Irvine Medical Center, 333 City Boulevard West, #400, Orange, CA 92868; douglaln{at}uci.edu
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 85 (12)
Cleveland Clinic Journal of Medicine
Vol. 85, Issue 12
1 Dec 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
Gregory T. Brennan, Alex Duong, Emily T. Nguyen, Douglas L. Nguyen
Cleveland Clinic Journal of Medicine Dec 2018, 85 (12) 923-924; DOI: 10.3949/ccjm.85a.18037

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
Gregory T. Brennan, Alex Duong, Emily T. Nguyen, Douglas L. Nguyen
Cleveland Clinic Journal of Medicine Dec 2018, 85 (12) 923-924; DOI: 10.3949/ccjm.85a.18037
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • STUDIES OF THE POTENTIAL RISKS
    • THE TORONTO CONSENSUS GUIDELINES
    • BENEFITS OF CONTINUING THERAPY
    • CONSIDERATIONS AFTER BIRTH: BREAST-FEEDING AND VACCINATION
    • OUR RECOMMENDATIONS
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Drug Therapy
  • Gastroenterology
  • Rheumatology
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire